Secondary Logo

Journal Logo

Articles by Wulf H. Utian

Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey

Gass, Margery L.S.; Stuenkel, Cynthia A.; Utian, Wulf H.; More

Menopause. 22(12):1276-1285, December 2015.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Why the product labeling for low-dose vaginal estrogen should be changed

Manson, JoAnn E.; Goldstein, Steven R.; Kagan, Risa; More

Menopause. 21(9):911-916, September 2014.

Letters to the Editor

Gass, Margery L.S.; Manson, JoAnn; Stuenkel, Cynthia; More

Menopause: The Journal of The North American Menopause Society. 19(7):836-837, July 2012.

The Chinese Utian Quality of Life Scale for women around menopause: translation and psychometric testing

Chen, Ping-Ling; Chao, Hsiang-Tai; Chou, Kuei-Ru; More

Menopause. 19(4):438-447, April 2012.

The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010)

Clarkson, Thomas B.; Utian, Wulf H.; Barnes, Stephen; More

Menopause. 18(7):732-753, July 2011.

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis

Pinkerton, JoAnn V.; Archer, David F.; Utian, Wulf H.; More

Menopause. 16(6):1102-1108, November-December 2009.

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women

Archer, David F.; Pinkerton, JoAnn V.; Utian, Wulf H.; More

Menopause. 16(6):1109-1115, November-December 2009.

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial

Pinkerton, JoAnn V.; Utian, Wulf H.; Constantine, Ginger D.; More

Menopause. 16(6):1116-1124, November-December 2009.

Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women

Bachmann, Gloria A.; Schaefers, Matthias; Uddin, Alkaz; More

Menopause. 16(5):877-882, September-October 2009.

NIH and WHI-time for a mea culpa and steps beyond*

Utian, Wulf H.

Menopause. 14(6):1056-1059, November-December 2007.

The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety

Stovall, Dale W.; Utian, Wulf H.; Gass, Margery L.S.; More

Menopause. 14(3):510-517, May-June 2007.

Effect of raloxifene on quality of life: a prospective study using the Utian Quality of Life (UQOL) Scale

Utian, Wulf H.; Janata, Jeffrey W.; Barbier, Suzanne; More

Menopause. 11(3):275-280, May-June 2004.

Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women

Utian, Wulf H.; Gass, Margery L. S.; Pickar, James H.

Menopause. 11(3):306-314, May-June 2004.